Business NewsMarketWire • Daxor Corporation (NYSE Amex: DXR) Announces Year End 2009 Earnings

Daxor Corporation (NYSE Amex: DXR) Announces Year End 2009 Earnings

Daxor Corporation (NYSE Amex: DXR) Announces Year End 2009 Earnings

NEW YORK, NY--(Marketwire - March 29, 2010) -  Daxor Corporation, (NYSE Amex: DXR), a medical instrumentation and biotechnology company, announced earnings today for the year ended December 31, 2009. The Company had basic and diluted earnings per share of $1.37 and $1.36 respectively in 2009, versus basic and diluted earnings per share of $3.48 and $3.46 per share, respectively in 2008. This reduction can be attributed to the decrease in other income to $12,261,060 in 2009 from $24,888,385 in 2008. More than 99% of the Company's other income consists of income from investments.

View More : http://www.marketwire.com/mw/release.do?id=1139073&sourceType=3
Releted News by marketwire
IIROC: Resumption; Financial 15 Split Corp.
TheStockAlarm Monday Morning Watchlist: Bank of America Corp., Citigroup Inc., Oracle Corp., ARCA Biopharma, Inc. and Converge Global Inc.
Daxor Corporation (NYSE Amex: DXR) Announces Year End 2009 Earnings